When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the world. This disorder is characterized by the loss of a protective neuronal ...

Relapsing Multiple Sclerosis: Navigating Treatment Conundrums This activity is supported by an educational grant from Novartis Pharmaceuticals, Inc.

Multiple sclerosis affects everyone differently. Learn what experts currently know about possible multiple sclerosis causes and risk factors, such as the immune system.

Multiple sclerosis can be difficult to diagnose. A diagnosis typically requires multiple tests to rule out other conditions with similar symptoms.

Navigate meal prep challenges with MS. Discover practical strategies for planning, shopping, adapting cooking methods, and simplifying cleanup to overcome fatigue, cognitive issues, and physical ...

In multiple sclerosis, the ability of clinicians to provide a prognosis for a patient and the design and interpretation of clinical trials both rely heavily on prognostic factors identified from ...

Learn about primary-progressive multiple sclerosis (PPMS), its symptoms, challenges in diagnosis, and treatment options. Discover the importance of symptom management and overall wellness.